COMMUNIQUÉS West-GlobeNewswire

Immunicum AB (publ) Announces Upcoming Presentations at Conferences in August and September

22/08/2017 - 08:00

Press Release 22 August 2017 Immunicum AB (publ) Announces Upcoming Presentations at Conferences in August and September Immunicum AB (publ; First North Premier: IMMU.ST) a biopharmaceutical company advancing a novel, [...]

Herantis Pharma's Manager's Transactions

22/08/2017 - 08:00

Herantis Pharma's Manager's Transactions Herantis Pharma Plc Company release 22 Aug 2017 at 9:00 am Herantis Pharma Oyj - Managers' Transactions ____________________________________________ Person subject to the [...]

Herantis Pharma's Manager's Transactions

22/08/2017 - 08:00

Herantis Pharma's Manager's Transactions Herantis Pharma Plc Company release 22 Aug 2017 at 9:00 am Herantis Pharma Oyj - Managers' Transactions ____________________________________________ Person subject to the [...]

Herantis Pharma's Manager's Transactions

22/08/2017 - 08:00

Herantis Pharma's Manager's Transactions Herantis Pharma Plc Company release 22 Aug 2017 at 9:00 am Herantis Pharma Oyj - Managers' Transactions ____________________________________________ Person subject to the [...]

Herantis Pharma's Manager's Transactions

22/08/2017 - 08:00

Herantis Pharma's Manager's Transactions Herantis Pharma Plc Company release 22 Aug 2017 at 9:00 am Herantis Pharma Oyj - Managers' Transactions ____________________________________________ Person subject to the [...]

Herantis Pharma's Manager's Transactions

22/08/2017 - 08:00

Herantis Pharma's Manager's Transactions Herantis Pharma Plc Company release 22 Aug 2017 at 9:00 am Herantis Pharma Oyj - Managers' Transactions ____________________________________________ Person subject to the [...]

Bavarian Nordic Announces Closing of Transaction with Janssen Pharmaceuticals, Inc. and Issue of Shares to Johnson & Johnson Innovation - JJDC, Inc.

21/08/2017 - 21:40

COPENHAGEN, Denmark, August 21, 2017 - Bavarian Nordic A/S (OMX: BAVA, OTC: BVNRY) today announced the closing of the transaction with Janssen Pharmaceuticals, Inc., part of the Janssen Pharmaceutical Companies of [...]

Sanofi : Disclosure of trading in own shares

21/08/2017 - 18:13

Disclosure of trading in own shares This announcement is distributed by NASDAQ OMX Corporate Solutions on behalf of NASDAQ OMX Corporate Solutions clients. The issuer of this announcement warrants that they are solely [...]

Sanofi : Déclaration des transactions sur actions propres

21/08/2017 - 18:13

Déclaration des transactions sur actions propres This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients. The issuer of this announcement warrants that they are [...]

Medtronic Receives CE Mark for Attain Stability(TM) Quad MRI SureScan(TM) Active-Fixation Heart Lead

21/08/2017 - 18:00

Clinical Trial Also Underway in U.S., Canada and Other Geographies DUBLIN - August 21, 2017 - Medtronic plc (NYSE: MDT) announced it has received CE ( Conformité Européene ) Mark for the Attain Stability(TM) Quad MRI [...]

CORRECTION - Ossur Hf : Transactions in relation to share buyback program

21/08/2017 - 16:22

This is a correction of the announcement from 16:00 21.08.2017 CEST, NO: 61/2017. Reason for the correction: Header incorrect, other information in the announcement is correct. Previous Header: Share buyback program [...]

PCI Biotech: Invitation to first half year 2017 presentation

21/08/2017 - 16:01

Oslo, 21 August 2017 - PCI Biotech invites to a presentation of the company's second quarter and first half year 2017 report on Tuesday 29 August 2017 at Oslo Cancer Cluster Innovation Park. Time: Tuesday August 29, [...]

Ossur Hf : Share buyback program completed

21/08/2017 - 16:00

Announcement from Össur hf. No. 61/2017 Reykjavík, 21 August 2017 On 15 August 2017, Össur hf. initiated a share buy-back program, see Company announcement no. 59/2017. The purpose of the share buyback program was to [...]

Novo Nordisk A/S - Share repurchase programme

21/08/2017 - 15:52

Bagsværd, Denmark, 21 August 2017 - On 2 February 2017, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No. 596/2014 of the European Parliament and Council of 16 April 2014 [...]

Shire plc Director and Senior Management Changes

21/08/2017 - 15:00

Shire plc Director and Senior Management Changes August 21, 2017 - Shire plc (LSE: SHP, NASDAQ: SHPG) ("Shire" or the "Company"), announces changes to its Executive Committee, as it progresses its strategy to sharpen [...]

PDMR Dealing

21/08/2017 - 11:41

LONDON, Aug. 21, 2017 (GLOBE NEWSWIRE) -- Verona Pharma plc (AIM:VRP) (NASDAQ:VRNA) ("Verona Pharma"), a clinical-stage biopharmaceutical company focused on developing and commercializing innovative therapies for [...]

Navamedic ASA: Enters into partnership agreement for distribution of ELMIRON® in the Nordics

21/08/2017 - 08:00

Oslo, August 21, 2017 - Navamedic ASA (OSE: NAVA), the Norwegian medtech and pharmaceutical products company, today announced it has entered into a long term agreement with bene-Arznemittel GmbH (bene) for the Nordic [...]

Saniona AB: Saniona's partner, Medix, initiates Phase 3 study for tesofensine in obesity

21/08/2017 - 08:00

PRESS RELEASE 21 August 2017 Saniona, a leading biotech company in the field of ion channels, today announces that Medix has recruited the first patients in the Phase 3 clinical study for tesofensine in Mexico. This [...]

Novartis and Medicines for Malaria Venture launch patient trial in Africa for KAF156, a novel compound against multidrug-resistant malaria

21/08/2017 - 07:15

Compound has potential to be a game-changer in malaria elimination, rapidly clearing malaria infection, including resistant strains, and blocking parasite transmission KAF156 is first compound from the [...]